Literature DB >> 8383202

Recurrent aphthous ulceration: a possible clinical manifestation of reactivation of varicella zoster or cytomegalovirus infection.

A Pedersen1, A Hornsleth.   

Abstract

The etiology of the most common intraoral mucosal disease, recurrent aphthous ulceration (RAU), remains obscure. Here, attempts were made to diagnose reactivation of varicella zoster (VZV), cytomegalovirus (CMV), Epstein-Barr (EBV) and human hepes virus 6 (HHV-6) infections from paired sera in association with RAU recurrences. The first sample was obtained within 3 days after a new recurrence (1) and the second 10-14 days later (2). The study initially comprised 18 otherwise healthy RAU patients (gr A) and 17 sex- and age-matched healthy non-RAU individuals. Values of specific antibody subclasses (IgM, IgG, IgA) were determined by ELISA (VZV, CMV, EBV) and IFA (HHV-6). Patients and controls exhibited differences in parameters on specific VZV IgM and CMV IgM. In order to substantiate these findings, specific VZV IgM and CMV IgM were subsequently also evaluated in 17 other RAU patients (gr B). Ten patients in gr A and 11 in gr B were IgM seropositive for either VZV and/or CMV in at least one of the serum samples, whereas in the controls only one was VZV IgM positive and none CMV IgM positive. Evaluated as groups, optometric density (OD) antibody levels of VZV IgM were significantly higher in the patients (gr A (1,2) vs controls: p < 0.0001; gr B (1,2) vs controls: p < 0.001). CMV OD IgM antibody values were significantly higher in gr B only (1,2 vs controls: p < 0.01). The study lends support for reactivation of VZV and/or CMV infection associated with RAU recurrences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383202     DOI: 10.1111/j.1600-0714.1993.tb00045.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Recurrent aphthous stomatitis.

Authors:  Sunday O Akintoye; Martin S Greenberg
Journal:  Dent Clin North Am       Date:  2014-01-21

2.  The seroprevalence of varicella zoster antibodies in Behçet's and other skin diseases.

Authors:  Sedat Akdeniz; Mehmet Harman; Selahattin Atmaca; Nezahat Akpolat
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease.

Authors:  Eun Bong Lee; Ye Jin Kwon; Ki Chul Shin; Yeong Wook Song; Chung-Gyu Park; Eung-Soo Hwang; Chang-Yong Cha
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

4.  Amlexanox for the treatment of recurrent aphthous ulcers.

Authors:  Juliette Bell
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 5.  The Contribution of Human Herpes Viruses to γδ T Cell Mobilisation in Co-Infections.

Authors:  Fanny Martini; Eric Champagne
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

6.  One-Year Period Prevalence of Oral Aphthous Ulcers and Oral Health-Related Quality of Life in Patients with Behçet's Disease.

Authors:  Mariko Naito; Yoshimi Suzukamo; Kenji Wakai; Miki Azechi; Fumio Kaneko; Takeo Nakayama; Nobuyuki Hamajima; Shunichi Fukuhara
Journal:  Genet Res Int       Date:  2014-03-09

7.  Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.

Authors:  Sónia Fonseca; Vanessa Pereira; Catarina Lau; Maria Dos Anjos Teixeira; Marika Bini-Antunes; Margarida Lima
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.